Mechanism of inactivation of ornithine transcarbamoylase by Ndelta -(N'-Sulfodiaminophosphinyl)-L-ornithine, a true transition state analogue? Crystal structure and implications for catalytic mechanism.

The crystal structure is reported at 1.8 A resolution of Escherichia coli ornithine transcarbamoylase in complex with the active derivative of phaseolotoxin from Pseudomonas syringae pv. phaseolicola, N(delta)-(N'-sulfodiaminophosphinyl)-l-ornithine. Electron density reveals that the complex is not a covalent adduct as previously thought. Kinetic data confirm that N(delta)-(N'-sulfodiaminophosphinyl)-l-ornithine exhibits reversible inhibition with a half-life in the order of approximately 22 h and a dissociation constant of K(D) = 1.6 x 10(-12) m at 37 degrees C and pH 8.0. Observed hydrogen bonding about the chiral tetrahedral phosphorus of the inhibitor is consistent only with the presence of the R enantiomer. A strong interaction is also observed between Arg(57) Nepsilon and the P-N-S bridging nitrogen indicating that imino tautomers of N(delta)-(N'-sulfodiaminophosphinyl)-l-ornithine are present in the bound state. An imino tautomer of N(delta)-(N'-sulfodiaminophosphinyl)-l-ornithine is structurally analogous to the proposed reaction transition state. Hence, we propose that N(delta)-(N'-sulfodiaminophosphinyl)-l-ornithine, with its three unique N-P bonds, represents a true transition state analogue for ornithine transcarbamoylases, consistent with the tight binding kinetics observed.

[1]  V. Stalon,et al.  L-arginine utilization by Pseudomonas species. , 1984, Journal of general microbiology.

[2]  N. Allewell,et al.  Substrate-induced conformational change in a trimeric ornithine transcarbamoylase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[3]  A. Ferguson,et al.  Phaseolotoxin: chlorosis, ornithine accumulation and inhibition of ornithine carbamoyltransferase in different plants. , 1980 .

[4]  R. Wolfenden,et al.  Transition state and multisubstrate analog inhibitors. , 1995, Methods in enzymology.

[5]  R. Read.  Improved Fourier Coefficients for Maps Using Phases from Partial Structures with Errors , 1986 .

[6]  D. Gigot,et al.  Synthesis and interaction with Escherichia coli L‐ornithine carbamoyltransferase of two potential transition‐state analogues , 1978, FEBS letters.

[7]  J. Gouaux,et al.  The catalytic mechanism of Escherichia coli aspartate carbamoyltransferase: a molecular modelling study. , 1987, Biochemical and biophysical research communications.

[8]  N. Guex,et al.  SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling , 1997, Electrophoresis.

[9]  J. L. Crawford,et al.  Crystal and molecular structures of native and CTP-liganded aspartate carbamoyltransferase from Escherichia coli. , 1982, Journal of molecular biology.

[10]  W. Cleland,et al.  13C and 15N isotope effects as a probe of the chemical mechanism of Escherichia coli aspartate transcarbamylase. , 1992, Biochemistry.

[11]  W. Lipscomb,et al.  Structure of unligated aspartate carbamoyltransferase of Escherichia coli at 2.6-A resolution. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[12]  N. Hoogenraad.  Synthesis and properties of delta-N-(phosphonacetyl)-L-ornithine. A transition-state analog inhibitor of ornithine transcarbamylase. , 1978, Archives of biochemistry and biophysics.

[13]  J. Wild,et al.  Protein differentiation: a comparison of aspartate transcarbamoylase and ornithine transcarbamoylase from Escherichia coli K-12. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[14]  T. Hoover,et al.  The DNA sequence of argI from Escherichia coli K12. , 1983, Nucleic acids research.

[15]  D. Hilvert,et al.  alpha-Functionalized phosphonylphosphinates: synthesis and evaluation as transcarbamoylase inhibitors. , 1999, Journal of medicinal chemistry.

[16]  N. Panopoulos,et al.  Phaseolotoxin transport in Escherichia coli and Salmonella typhimurium via the oligopeptide permease , 1980, Journal of bacteriology.

[17]  J. Morrison,et al.  [17] The kinetics of reversible tight-binding inhibition , 1979 .

[18]  W. Lipscomb,et al.  Complex of N-phosphonacetyl-L-aspartate with aspartate carbamoyltransferase. X-ray refinement, analysis of conformational changes and catalytic and allosteric mechanisms. , 1988, Journal of molecular biology.

[19]  C. Greenblatt,et al.  Isolation of a carbohydrate‐rich immunologically active factor from cultures of Leishmania tropica , 1977, FEBS letters.

[20]  J. Navaza,et al.  AMoRe: an automated package for molecular replacement , 1994 .

[21]  H. K. Schachman,et al.  Structural similarity between ornithine and aspartate transcarbamoylases of Escherichia coli: Characterization of the active site and evidence for an interdomain carboxy‐terminal helix in ornithine transcarbamoylase , 1996, Protein science : a publication of the Protein Society.

[22]  W. Niemczura,et al.  Inhibitors of Ornithine Carbamoyltransferase from Pseudomonas syringae pv. phaseolicola. st]Revised Structure of Phaseolotoxin , 1984 .

[23]  J M Thornton,et al.  LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. , 1995, Protein engineering.

[24]  V. Villeret,et al.  Crystal structure of Pseudomonas aeruginosa catabolic ornithine transcarbamoylase at 3.0-A resolution: a different oligomeric organization in the transcarbamoylase family. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. G. Waley,et al.  Kinetics of inactivation of beta-lactamase I by 6 beta-bromopenicillanic acid. , 1980, Biochemical Journal.

[26]  C. Legrain,et al.  Ornithine carbamoyltransferase from Escherichia coli W. Purification, structure and steady-state kinetic analysis. , 1976, European journal of biochemistry.

[27]  R. Bieleski,et al.  Involvement of phaseolotoxin in halo blight of beans: transport and conversion to functional toxin. , 1977, Plant physiology.

[28]  J. Richardson,et al.  Covalent alternatives for the elusive iminophosphonium cation. Crystal structures of PCl(NPri2)2NPh·AlCl3 and P(NPri2)2[NPh(SO2CF3)]O , 1991 .

[29]  B. Seaton,et al.  Crystal structure at 2.8 Å resolution of anabolic ornithine transcarbamylase from Escherichia coli , 1997, Nature Structural Biology.

[30]  G. Stark,et al.  Aspartate transcarbamylase. Interaction with the transition state analogue N-(phosphonacetyl)-L-aspartate. , 1971, The Journal of biological chemistry.

[31]  W. Lipscomb,et al.  2.5 A structure of aspartate carbamoyltransferase complexed with the bisubstrate analog N-(phosphonacetyl)-L-aspartate. , 1987, Journal of molecular biology.

[32]  D. Shi,et al.  1.85-A resolution crystal structure of human ornithine transcarbamoylase complexed with N-phosphonacetyl-L-ornithine. Catalytic mechanism and correlation with inherited deficiency. , 1998, The Journal of biological chemistry.

[33]  V. Schramm.  Enzymatic transition-state analysis and transition-state analogs. , 1999, Methods in enzymology.

[34]  L. E. Parmentier,et al.  Studies on the urea cycle enzyme ornithine transcarbamylase using heavy atom isotope effects. , 1998, Biochimica et biophysica acta.

[35]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[36]  W. Lipscomb,et al.  Substrate specificity and protonation state of ornithine transcarbamoylase as determined by pH studies. , 1985, Biochemistry.

[37]  R. Mitchell.  Bean halo-blight toxin , 1976, Nature.

[38]  M. Arisawa,et al.  Inactivation of TEM-1 beta-lactamase by 6-acetylmethylenepenicillanic acid. , 1983, The Biochemical journal.